Hempola References

1. Health Canada, "Nutrition Recommendations, The Report of the Scientific Review Committee," 1990.

2. van Papendort, D.H. et al. Biochemical Profile of Osteoporotic Patients on Essential Fatty Acid Supplementation, Nutrition Research, Vol. 15, No. 3.

3. Buck,A.C. et al. "The Treatment of Idiopathic Recurrent Urolithiasis With Fish Oil and Evening Primrose Oil- A Double Blind Study, " Urolithiasis 2, Plenum Press, New York, 1994.

4. Declair, V. The usefulness of topical application of essential fatty acids (EFA) to prevent pressure ulcers, Ostomy Wound Manage 1997 Jun:43(5):48-52,54.

5. Zurier,RB, et al. Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial, Arthritis Rheum 1996 Nov:39(11).

6. Leventhal LJ, et al. Treatment of rheumatoid arthritis with gamma-linolenic acid, Ann Intern Med 1993 Nov 1;119(9).

7. Villani F, et al. Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyper reactivity in subjects with seasonal asthma, Respiration 1998;65(4).

8. Rossetti, RG, et al. Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation,
J Leukoc Biol 1997 Oct;62(4).

9. Leaf A; Kang J. Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence, J Intern Med 1996 Jul;240(1).

10. Toft I, et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial, Ann Intern MEd 1995 Dec 15:123(12).

11. Hartman, IS. Alpha-linolenic acid: a preventive in secondary coronary events? Nutr Rev 1995 Jul;53(7).

12. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease, Prostaglandins Leukot Essent Fatty Acids 1995 June;52(6).

13. Felton CV, et al. Dietary polyunsaturated fatty acids and composition of human aortic plaques, Lancet 1994 Oct 29;344(8931).

14. Hardy Sc; Kleinman RE. Fat and cholesterol in the diet of infants and young children: implications for growth, development, and long-term health, J Pediatr 1994 Nov;125(5 Pt 2).

15. Wagner W; et al. Prophylactic treatment of migraine with gamma-linolenic and alpha-linolenic acids, Cephalagia 1997 Apr;17(2).

16. Deferne JL; Leeds AR. Resting blood pressure and cardiovascular reactivity to mental arithmetic in mild hypertensive males supplemented with blackcurrant seed oil, J Hum Hypertens 1996 Aug;10(8).

17. Kruger Mc; Horrobin DF. Calcium metabolism, osteoporosis and essential fatty acids: a review, Prog Lipid Res 1997 Sep;36(2-3).

18. Callaway JC et al. Occurence of omega 3 stearidonic acid in hemp seed, Journal of the IHA Vol 3, No 2,1997.

19. Deferne JL, Pate DW. Hemp seed oil: A source of valuable essential fatty acids, Journal of the IHA Vol 3, No 1, 1996.

20. Schmidt, Michael. "Smart Fats," Frog Ltd. Berkley, California 1997.

21. Willatts P. Long-chain polyunsaturated fatty acids supplementation associated with infant intelligence, Lancet 1998;352.

22. Connor We, et al. Essential fatty acids: the importance of n3 fatty acids in the retina and brain, Nutr Rev 1992 Apr;50(4).

23. Leson G; Pless P. "Hemp Foods & Oils for Health," HEMPTECH California 1999.

Diabetic References

1. Das, UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease, Prosta Leukot Essent Fatty Acids 1995 Jun;52(6).

2. Horrobin, DF. Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease?, Prosta Leukot Essent Fatty Acids 1995 Dec;53(6).

3. Holler C et al. Eicosanoid precursers: potential factors for atherogenesis in diabetic CAPD patients?, Perit Dial Int 1996;16 Suppl 1.

4. Goh YK, et al. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients, Diabetologia 1997 Jan;40(1).

5. Horrobin, DF. Essential fatty acids in the management of impaired nerve function in diabetes, Diabetes 1997 Sep;46 Suppl 2.

6. Jamal GA. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy, Diabet Med 1994 Mar;11(2).

7. Roberts TL et al. Linoliec acid and risk of sudden cardiac death, Br Heart J 1993 Dec;70(6).

8. Keen H et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group, Diabetes Care 1993 Jan;16(1).

9. Arisaka M et al. Fatty acid and prostaglandin metabolism in children with diabetes mellitus II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels, Prost Leukot Essent Fatty Acids 1992 Jul;43(3).